Sample Collection for the Development and Evaluation of Rapid Tests for Chlamydia trachomatis and Neisseria gonorrhoeae – outside of US (OUS).


Chlamydia trachomatis (CT) and Neisseria gonorrhoeae (NG) infections are significant contributors to avoidable infertility. Many cases of CT and NG go undiagnosed and unreported, leading to frequent reinfection and ongoing transmission. In the United States, CT and NG are the most commonly reported notifiable infectious diseases, with approximately 1.8 million chlamydia cases and over 600,000 gonorrhea cases reported in 2019 alone.

The Centers for Disease Control and Prevention (CDC) recommends annual chlamydia screening for all sexually active women under 25 years old, as well as older women with risk factors like new or multiple partners or a partner with a known sexually transmitted infection (STI). Routine screening is not advised for men; however, men who have sex with men (MSM) and have had sexual intercourse should undergo annual screening for urethral chlamydial infection.

The development and utilization of rapid, sensitive nucleic acid-based tests for detecting CT and NG are crucial in screening efforts aimed at reducing the incidence and impact of these infections.


  • Wits RHI
  • Prof. Thesla Palanee-Phillips (Co-Principal Investigator)

Latest Update

April 2024

For more details about ABBOTT please email

Research and Policy Briefs


Stay up to date

Get updates on news, resources, events and happenings from Wits RHI.